(PharmaNewsWire.Com, January 05, 2017 ) Publisher's clinical trial report, "Dental Caries Global Clinical Trials Review, H1, 2016" provides an overview of Dental Caries clinical trials scenario. This report provides top line data relating to the clinical trials on Dental Caries. Report includes an...
(PharmaNewsWire.Com, January 05, 2017 ) Publisher's clinical trial report, "Bacteriuria Global Clinical Trials Review, H1, 2016" provides an overview of Bacteriuria clinical trials scenario. This report provides top line data relating to the clinical trials on Bacteriuria. Report includes an overview...
(PharmaNewsWire.Com, January 05, 2017 ) Publisher's clinical trial report, "Leprosy Global Clinical Trials Review, H1, 2016" provides an overview of Leprosy clinical trials scenario. This report provides top line data relating to the clinical trials on Leprosy. Report includes an overview of trial...
(PharmaNewsWire.Com, January 05, 2017 ) Publisher's clinical trial report, "Leishmaniasis (Kala-Azar) Global Clinical Trials Review, H1, 2016" provides an overview of Leishmaniasis (Kala-Azar) clinical trials scenario. This report provides top line data relating to the clinical trials on Leishmaniasis...
(PharmaNewsWire.Com, January 06, 2017 ) The weight loss and obesity management market includes products, services and therapies for reducing or managing weight in overweight and obese patients. According to the World Health Organization (WHO) definition, body mass index (BMI) greater than or equal...
(PharmaNewsWire.Com, January 05, 2017 ) According to Publisher, the Global Viral Molecular Diagnostics Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Growing incidence of viral diseases, rising aged population, technological advances...
(PharmaNewsWire.Com, January 05, 2017 ) Report SummaryCancer is a group of diseases characterized by abnormal cell growth. It is a multi-step process, as a single mutation is almost certainly insufficient to cause a cell to become malignant. A number of cellular processes must be deregulated to allow...
(PharmaNewsWire.Com, January 06, 2017 ) Branded generics are the drugs which are biosimilars to the innovator products and marketed under different brand names. In other words, branded generics, sometimes also called as ‘value-added generics’ can either be a novel dosage form of an original patented...
(PharmaNewsWire.Com, January 06, 2017 ) Halal pharmaceuticals are those medicines that stringently adhere to Shariah law. More specifically, halal pharmaceuticals refer to medicines that should not contain any parts of animals (dogs, pigs and ones particularly with pointed teeth), insects (bees),...
(PharmaNewsWire.Com, January 06, 2017 ) Dermal filler is the non-invasive treatment for facial rejuvenation and are used to as anti-ageing agents. As people age, facial skin begins to lose its flexibility and natural hydration that helps support, shape and add volume to the face. This leads to wrinkles...
(PharmaNewsWire.Com, January 06, 2017 ) Market OverviewThe rising incidence rate of hearing disorders among the geriatric population has resulted in growing sales of efficient hearing devices. The hearing disabilities among war veterans as well as new-born infants is one of the biggest concerns...
(PharmaNewsWire.Com, January 05, 2017 ) DelveInsight's, " Indolent Lymphoma-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Indolent Lymphoma. The DelveInsight'sReport covers the product profiles in various stages of development...
(PharmaNewsWire.Com, January 05, 2017 ) DelveInsight's, "Tumor Necrosis Factor Alpha (TNF-a) Agonists-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Tumor Necrosis Factor Alpha (TNF-a) Agonists. The DelveInsight's Report...
(PharmaNewsWire.Com, January 05, 2017 ) DelveInsight's Report, "Gastric Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key...
(PharmaNewsWire.Com, January 05, 2017 ) Publisher's, "11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1) Inhibitors-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ßHSD1)...
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
